Tarian Pharma – winner of 2022 iLab Edition
Tarian Pharma are grateful to have been selected as a winner of the 2022 iLAB competition on July 4th, 2022. This National contest is organised by the Ministry of Higher Education, Research and Innovation and is implemented by BPI France. From an initial selection of 396 dossiers in the domains of digital, engineering and health … Continue reading Tarian Pharma – winner of 2022 iLab Edition
Tarian Pharma Achievements in 2021
Tarian Pharma Achievements in 2021 Drug development achievements CMC: Long term stability of TAR-0520 gel at 25°C and 40°C has been confirmed Nonclinical: Completion of toxicology package allowing entrance in the first clinical study in cancer patients Clinical Pharmacology: Demonstration of skin bioavailability and pharmacological performance over 24 hours with our lead candidate TAR-0520 gel … Continue reading Tarian Pharma Achievements in 2021